Hip pain isn't always caused by what appears on an X-ray or MRI. The most important step in treatment is first identifying the true source of your symptoms. Learn how diagnostic hip injections help physicians pinpoint pain generators and create more effective, targeted treatment plans.
What a Diagnostic Hip Injection Actually Does
A diagnostic hip injection serves a dual purpose. It delivers a local anesthetic, often an anti-inflammatory agent, directly into a specific anatomical target within or around the hip joint, and it uses the body's response to that injection as a clinical diagnostic tool.
If a patient experiences significant, reproducible pain relief within minutes of the injection, it confirms that the targeted structure is the primary pain generator. If relief is partial or absent, it redirects the diagnostic workup toward other potential sources, the lumbar spine, the sacroiliac joint, surrounding bursae, or the extra-articular soft tissues. This level of diagnostic precision is something that imaging alone, including MRI, cannot always provide.
Common Targets for Diagnostic Hip Injections
The intra-articular hip joint injection is the most frequently performed, targeting the space between the femoral head and acetabulum to evaluate for hip labral tears, cartilage defects, femoroacetabular impingement (FAI), and synovitis. It is performed under fluoroscopic or ultrasound guidance to ensure accurate needle placement in a joint that is anatomically inaccessible without imaging assistance.
Other common injection targets include the trochanteric bursa for lateral hip pain associated with greater trochanteric pain syndrome, the iliopsoas bursa for anterior groin pain related to snapping hip syndrome, and the sacroiliac joint for pain that straddles the hip and lower back. Each target has a distinct symptom profile and response pattern that helps the treating physician build a precise anatomical picture of the pain source.
From Diagnosis to Treatment: Where Regenerative Medicine Enters
What makes diagnostic hip injections particularly valuable at the American Hip Institute is that the diagnostic step and the therapeutic step can often be combined or sequenced efficiently once the pain source is confirmed.
For patients whose diagnostic injection confirms intra-articular hip pathology, cartilage damage, labral irritation, or early joint deterioration, regenerative medicine delivered into the same confirmed target offers a biologically active treatment that goes beyond symptom management. Platelet-Rich Plasma (PRP) therapy concentrates growth factors drawn from the patient's own blood and delivers them directly to damaged tissue, stimulating the body's natural repair mechanisms at the cellular level, an approach that is particularly well-suited to early hip joint degeneration and soft tissue pathology.
Cell therapy represents the most advanced regenerative option available for patients with confirmed hip pathology. Using the body's own regenerative cells harvested from bone marrow or adipose tissue, this approach introduces concentrated reparative material directly into the joint environment, targeting the biological conditions that drive degeneration rather than simply managing the resulting pain.
Viscosupplementation, the injection of hyaluronic acid to restore joint lubrication and reduce friction, offers an additional non-surgical option for patients with confirmed joint space changes.
All three regenerative approaches are part of the comprehensive non-surgical treatment options available at the American Hip Institute, where every treatment decision is guided by the same research-based framework that has produced over 550 peer-reviewed publications and more than 10,000 hip procedures performed.
Why Confirming the Diagnosis First Produces Better Outcomes
One of the most important principles in hip preservation is precision of delivery. Regenerative therapies, injection treatments, and surgical planning all depend on accurate identification of the pain source to produce their intended effect. A diagnostic injection that confirms the precise anatomical origin of pain is not a preliminary step, it is the foundation of a treatment plan designed to work.
Patients who proceed directly to treatment without a confirmed diagnosis risk directing therapy to the wrong target, producing suboptimal outcomes that may lead them to conclude treatment failed, when the problem was never the therapy, it was the targeting.
The Right Starting Point for Hip Pain That Has Not Been Explained
If you have been managing hip pain with activity modification, physical therapy, or anti-inflammatory medication without a clear structural diagnosis, a diagnostic injection may be the clinical step that finally brings clarity and opens the door to a targeted treatment plan designed around what is actually causing your pain.
Frequently Asked Questions
- What is a diagnostic hip injection?
A diagnostic hip injection uses medication to help identify the specific source of hip pain. - Are diagnostic hip injections painful?
Most patients experience only mild discomfort during the procedure. - How long does the procedure take?
A diagnostic hip injection is typically completed in less than 30 minutes. - Can a diagnostic injection help avoid unnecessary surgery?
Yes. By identifying the true pain source, injections can help guide the most appropriate treatment plan.
Reference Links:
- Intra-Articular Hip Injection Using Anatomic Surface Landmarks - PubMed Central
- Intra-articular Hip Injection Using Anatomical and Radiological Landmarks Without the Use of Ultrasound or Radiological Guidance - PubMed Central
AUTHOR: Benjamin D. Kuhns, MD, MS – Orthopedic Hip Surgeon & Research Director
Benjamin D. Kuhns, MD, MS is a board-certified orthopedic surgeon and Director of Research at the American Hip Institute in Des Plaines and Chicago, Illinois. He specializes in comprehensive hip care, including hip preservation, arthroscopy, open osteotomies, and primary and revision anterior approach hip arthroplasty. Dr. Kuhns also incorporates regenerative medicine techniques into personalized treatment strategies designed to restore function and accelerate return to activity.
Credentials & Recognition
Dr. Kuhns completed his Bachelor of Arts at Colgate University with a major in chemistry and a minor in history, followed by a Master of Science in Neuroscience from Northwestern University. He earned his medical degree from Case Western Reserve University School of Medicine, graduating with distinction in research and being inducted into the Alpha Omega Alpha honor society. He then completed orthopedic residency training at the University of Rochester Medical Center, where he received the Kenneth DeHaven Research Award for work linking femoroacetabular impingement to hip osteoarthritis. Following residency, Dr. Kuhns pursued fellowship training in adult hip preservation and reconstruction at The Steadman Clinic and completed advanced hip preservation training at the American Hip Institute. He has authored more than 40 peer-reviewed articles and book chapters on hip dysfunction and surgical management.
Clinical Expertise
Dr. Kuhns’ clinical focus includes non-operative management of hip pain through targeted physical therapy and injections, complex primary and revision hip arthroscopy, open hip preservation including periacetabular and femoral osteotomies, and robotic anterior approach total hip arthroplasty. In his role as a surgeon and researcher, he collaborates closely with patients to craft customized treatment plans aimed at optimizing functional outcomes and helping individuals return to the activities they enjoy, regardless of age. He is an active member of professional organizations, including the American Academy of Orthopaedic Surgeons and The Hip Preservation Society (ISHA).
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Kuhns or another qualified orthopedic specialist at the American Hip Institute.
AUTHOR: Etan P. Sugarman, M.D., FAAOS - Orthopedic Joint Preservation & Sports Medicine Surgeon
Etan P. Sugarman, M.D., FAAOS is a board-certified orthopedic surgeon specializing in joint preservation, hip arthroscopy, hip replacement, sports medicine, and regenerative medicine. He serves as Director of Joint Preservation at the American Hip Institute, where he focuses on advanced, minimally invasive solutions for complex hip, shoulder, and knee conditions to help patients return to active lifestyles.
Credentials & Recognition
Dr. Sugarman earned his undergraduate degree from New York University, where he was recognized for academic excellence. He received his medical degree from the University of Illinois College of Medicine and completed his orthopedic surgery residency at the University of Michigan, where he served as Chief Resident. Following residency, Dr. Sugarman completed fellowship training in adult hip reconstructive and preservation surgery at the world-renowned Steadman Philippon Research Institute in Vail, Colorado, an experience that deepened his expertise in advanced hip arthroscopy, osteotomy, and joint preservation techniques. He is a Fellow of the American Academy of Orthopaedic Surgeons (FAAOS) and is actively involved in hip preservation research, clinical innovation, and education for both patients and the orthopedic community.
Clinical Expertise
Dr. Sugarman’s clinical practice encompasses the full spectrum of hip care, ranging from non-operative management, including injections and physical therapy, to cutting-edge surgical interventions. His areas of expertise include hip arthroscopy for femoroacetabular impingement and labral tears, periacetabular osteotomy for hip dysplasia, complex revision surgery, and anterior approach total hip arthroplasty. He emphasizes a patient-centered approach, integrating evidence-based surgical techniques with individualized rehabilitation plans to promote optimal recovery and long-term function. Dr. Sugarman also contributes to peer-reviewed scientific literature and is dedicated to advancing the field of hip preservation and reconstruction.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Sugarman or another qualified orthopedic specialist at the American Hip Institute.